Concord Biotech Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 10,457,825 (50%) | — | ₹77,492 Cr |
| NII (HNI) | — | 3,137,348 (15%) | — | ₹23,248 Cr |
| Retail | — | 7,320,479 (35%) | — | ₹54,245 Cr |
| Employee | — | 10,000 (0%) | — | ₹7 Cr |
| Σ Total | — | 20,925,652 (100%) | — | ₹1,550,591 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,820 |
| Retail (Max) | 13 | 260 | ₹192,660 |
| S-HNI (Min) | 14 | 280 | ₹207,480 |
| B-HNI (Min) | 67 | 1,340 | ₹992,940 |
Financial Statements Amount in Crore
| Metric | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 631 | 736 | 888 |
| Profit After Tax | 235 | 175 | 240 |
| Net Worth | 999 | 1,103 | 1,290 |
| Total Assets | 1,183 | 1,313 | 1,514 |
| Total Borrowing | 86 | 61 | 31 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- –
Company Overview
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.